Related references
Note: Only part of the references are listed.Systematic literature review and network meta-analysis of sodium-glucose co-transporter inhibitors vs metformin as add-on to insulin in type 1 diabetes
Bryony E. Langford et al.
DIABETES OBESITY & METABOLISM (2020)
A Novel Dual-Hormone Insulin-and-Pramlintide Artificial Pancreas for Type 1 Diabetes: A Randomized Controlled Crossover Trial
Ahmad Haidar et al.
DIABETES CARE (2020)
Excluding non-English publications from evidence-syntheses did not change conclusions: a meta-epidemiological study
B. Nussbaumer-Streit et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2020)
ICE guidance on sotagliflozin for type 1 diabetes
Amanda I. Adler et al.
LANCET DIABETES & ENDOCRINOLOGY (2020)
GLP-1 receptor agonists in type 1 diabetes: a MAG1C bullet?
Michael A Nauck et al.
Lancet Diabetes & Endocrinology (2020)
Optimising the Benefits of SGLT2 Inhibitors for Type 1 Diabetes
Marc Evans et al.
DIABETES THERAPY (2020)
CINeMA: An approach for assessing confidence in the results of a network meta-analysis
Adriani Nikolakopoulou et al.
PLOS MEDICINE (2020)
Risk factors and prevention strategies for diabetic ketoacidosis in people with established type 1 diabetes
Dominic Ehrmann et al.
Lancet Diabetes & Endocrinology (2020)
International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) Inhibitors
Thomas Danne et al.
DIABETES CARE (2019)
The number needed to treat in pairwise and network meta-analysis and its graphical representation
Areti Angeliki Veroniki et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2019)
Incretin-based therapies for patients with type 1 diabetes: a meta-analysis
Lili Liu et al.
ENDOCRINE CONNECTIONS (2019)
Effects of sodium-glucose cotransporter (SGLT) inhibitors in addition to insulin therapy on glucose control and safety outcomes in adults with type 1 diabetes: A meta-analysis of randomized controlled trials
Jingli Lu et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2019)
Efficacy and safety of dual SGLT 1/2 inhibitor sotagliflozin in type 1 diabetes: meta-analysis of randomised controlled trials
Giovanni Musso et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition
Pouya Saeedi et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2019)
RoB 2: a revised tool for assessing risk of bias in randomised trials
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
NICE guidance on dapagliflozin with insulin for type 1 diabetes
Amanda I. Adler et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
A Model-Based Meta-Analysis of 24 Antihyperglycemic Drugs for Type 2 Diabetes: Comparison of Treatment Effects at Therapeutic Doses
Alan Maloney et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Empagliflozin as Adjunctive to Insulin Therapy in Type 1 Diabetes: The EASE Trials
Julio Rosenstock et al.
DIABETES CARE (2018)
Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial
John R. Petrie et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial
Chantal Mathieu et al.
DIABETES CARE (2016)
Non-insulin drugs to treat hyperglycaemia in type 1 diabetes mellitus
Christian Seerup Frandsen et al.
LANCET DIABETES & ENDOCRINOLOGY (2016)
Model-Based Network Meta-Analysis: A Framework for Evidence Synthesis of Clinical Trial Data
D. Mawdsley et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2016)
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
Brian Hutton et al.
ANNALS OF INTERNAL MEDICINE (2015)
Ranking treatments in frequentist network meta-analysis works without resampling methods
Gerta Ruecker et al.
BMC MEDICAL RESEARCH METHODOLOGY (2015)
Current State of Type 1 Diabetes Treatment in the US: Updated Data From the T1D Exchange Clinic Registry
Kellee M. Miller et al.
DIABETES CARE (2015)
Predictive distributions were developed for the extent of heterogeneity in meta-analyses of continuous outcome data
Kirsty M. Rhodes et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2015)
Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews
Rebecca M. Turner et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2012)
Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies
J. P. T. Higgins et al.
RESEARCH SYNTHESIS METHODS (2012)
Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool
Georgia Salanti
RESEARCH SYNTHESIS METHODS (2012)
Using network meta-analysis to evaluate the existence of small-study effects in a network of interventions
Anna Chaimani et al.
RESEARCH SYNTHESIS METHODS (2012)
Network meta-analysis, electrical networks and graph theory
Gerta Ruecker
RESEARCH SYNTHESIS METHODS (2012)
Checking consistency in mixed treatment comparison meta-analysis
S. Dias et al.
STATISTICS IN MEDICINE (2010)
Meta-analyses involving cross-over trials: methodological issues
DR Elbourne et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2002)
Share Paper
